中国快讯 (China Crunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
China Biotech News: Beijing’s Drive Amid US Decoupling
China biotech news on Beijing’s push to pair chip self-reliance with biotech scale, reshaping trials, devices and US-China cooperation in 2024.
Hong Kong leads world-first robotic liver transplant
Hong Kong surgeons reportedly completed a world-first robotic liver transplant from a living donor, raising questions about minimally invasive benefits, training, and oversight.
Morgan Stanley boosts China humanoid robots outlook
Morgan Stanley boosted its outlook for China humanoid robots, lifting the shipment forecast to 50,000 units and highlighting faster adoption and scaling.
AI-driven cyberfraud: Interpol warns Asia of scams
Interpol warns AI-driven cyberfraud is spreading across Asia, making scams more deceptive and pressuring banks, platforms, and police to harden defenses.
Hong Kong Data Privacy Academy Launch Builds Talent
Hong Kong launches a data privacy academy to raise compliance skills, standardise training, and help organisations meet data privacy regulations and audits.
Xpeng robotics expansion: CEO takes direct control
Xpeng robotics expansion accelerates as CEO He Xiaopeng takes direct control of the robotics unit, prioritising AI-driven humanoids for scale.
Humanoid robots in China: fast track to factory use
Factory pilots are scaling humanoid robots in China for material handling, inspection, and 3C support, as policy, safety standards, and supply chains mature.
AI Advances in Chinese Home Robotics Training
AI advances in Chinese home robotics training accelerate learning with simulated environments, enhancing domestic robot capabilities and safety.
DeepSeek AI funding: Tencent and CATL near US$7b
DeepSeek AI funding talks reportedly near a first US$7b round with Tencent and CATL, reshaping China’s model race, valuation benchmarks, and API growth.
Akeso lung cancer drug trial boosts hopes for US$20b market
Akeso lung cancer drug trial results are cautiously boosting optimism for a US$20b market as investors track data quality, timelines, and next regulatory steps.
Advertisement
